Poster
Modeling Supports Determination of First-In-Human Dosing and Rapid Titration to Final Dose for Subcutaneous Administration of LIPO-102.
Presented by Lithera and Rosa at American Conference on Pharmacometrics (ACoP), 2011
Oral Presentation
Whether, How Much, and Why: Integrating Modeling and Systems Biology Approaches To Answer Questions About Use of Ursodiol in Neonates.
Presented by Vitalea and Rosa at the International Conference on Systems Biology (ICSB), 2011
Poster
Comparison of NLME and Mechanistic Physiological Modeling using Examples in Drug Discovery and Development
Presented by Rosa at the Population Approach Group in Europe (PAGE), 2011
Oral Presentation
Creating and Using a Physiological Model to Evaluate GPR119 Agonism as a Diabetes Therapy
Presented by Pfizer and Rosa at World PKPD Summit, 2011
Poster
Impact of Modeling on GPR119 Agonist Development
Presented by Pfizer and Rosa at American Conference on Pharmacometrics (ACoP), 2011
Poster
Qualifying Mechanistic Physiological Models for Use in Pharmaceutical Discovery and Development
Presented by Rosa at the American Conference on Pharmacometrics (ACoP), 2011
Workshop
Short Course: Optimizing Lead Compound Selection Using Mechanistic Physiological Modeling and Qualifying Mechanistic Physiological Models for Use in Pharmaceutical Discovery and Development
Presented by Rosa at the European Federation for Medicinal Chemistry (EFMC), 2011
Oral Presentation
Modeling Complex Mechanisms of Action in Diabetes Therapy
Presented by Rosa at the American Conference on Pharmacometrics (ACoP), 2011
